PRIOR ACADEMIC RANK AND POSITION

• Voluntary Teaching Staff

• Department of Medicine

• AtlanticCare Regional Medical Center (formerly Atlantic City Medical Center), Atlantic City

EDUCATION

Dr Sandra Hollander graduated from the State University of New York at Syracuse, College of Environmental Science and Forestry in 1977 obtaining a Bachelor of Science degree with a Grade Point Average of 3.7.

She continued to Graduate School at the State University of New York at Buffalo, Roswell Park Memorial Institute obtaining her Master’s Degree in Experimental Pathology – September 1, 1979 with a Grade Point Average of 3.7.

Dr Sandra Hollander research, thesis and Master’s degree (taken in the Medical Campus) were accepted as her first two years of Medical School.  She entered Ross University School of Medicine as a third year student and performed all her Clinical Rotations in US.  She obtained her MD Degree in 1981.

Her Internship and Residency was at the prestigious St. Barnabas Medical Center in Livingston, NJ, completed in 1984.

Dr Sandra Hollander found her niche in Medicine was in Hematology and Oncology and entered a combined fellowship at the prestigious State University of New York at Stony Brook, University Hospital and VA Medical Center at Northport, New York.  She completed this dual fellowship in 1987.

BOARD CERTIFICATION

American Board of Internal Medicine

• Oncology Sub specialty Board Certification – November, 1987

• Hematology Sub specialty Board Certification – November, 1986

• Internal Medicine – September, 1984

MEDICAL LICENSURE

Active in

• Georgia

• New Jersey

• Pennsylvania

• Tennessee

HONORS AND AWARDS

Undergraduate:

• Graduated Magna Cum Laude

• Member of Phi Kappa Phi Honor Society

• Member of Alpha Xi Sigma Honor Society

Graduate:

Graduated Magna Cum Laude

Post Graduate: A Fellow in the American College of Physicians (FACP) – Jan. 1, 1997 PROFESSIONAL POSITIONS

Reliance Medical Group, Galloway, NJ 2012- 2013 Atlantic Hematology Oncology Group, Galloway, New Jersey, 1990 –2012. For many years Dr. Hollander was the leader of this “Patientcentric” practice that focused on the patient.

Former clinician at the AtlantiCare Cancer Care Institute (formerly RNS Regional Cancer Center at the Atlantic City Medical Center). Clinical Assistant Professor of Medicine Division of Hematology / Oncology University of Medicine and Dentistry of New Jersey  Stratford, New Jersey 1988 -1990

Co-coordinator of Ambulatory Care Sickle Cell Program, Camden, New Jersey, 1989 – 1990

EDUCATION – TEACHING

Preceptor:

• Introduction to Clinical Medicine

• State University of New York at Stony Brook

• Northport VA Medical Center

Supervisor:

Internal Medicine Residents, University of Medicine and Dentistry, Stratford, NJ, 1988 – 1990

Teaching:

Voluntary Teaching Staff, Atlantic City Medical Center, Residency Program

ADMINISTRATIVE ACTIVITIES

Director

Division of Hematology and Oncology, AtlanticCare Regional Medical Center (formerly Atlantic City Medical Center), Atlantic City and Pomona, NJ, 1995 – 1998

Past Member

• Transfusion Committee,

• Clinical Research Committee

• Cancer Committee

Participant

Quality Assessment

PROFESSIONAL AND SOCIETY MEMBERSHIPS

• American Medical Association

• American College of Physicians (Past)

• American Society of Clinical Oncology

PUBLICATIONS

• MASTER’S THESIS – “A STUDY OF PLATELET AGGREGATION INHIBITORS ON NEPHROBLASTOMA IN WISTAR-FURTH STRAIN RATS,” S. L. Gordon; Buffalo, New York, 1979.

• “STUDIES ON PLATELET AGGREGATION INHIBITORS IN VIVO VIII.  EFFECT OF PENTOXIFYLLINE ON SPONTANEOUS TUMOR METASTASIS,” S. Gordon, J. L. Ambrus, MD, et. al., J. of Med., Vol.10, No.6, 1979, P.435- 443.

• “IDENTIFICATION OF TISSUE FACTOR IN TWO HUMAN PANCREATIC CANCER CELL LINES,” J. M. Silberberg, MD, S. Gordon, MD, S. Zucker, MD, Clinical Research (Abstract) Vol. 34; No.3 Sept. 1986, P.882A.

• “HEMOLYTIC UREMIC SYNDROME IN A PATIENT WITH SMALL CELL LUNG CANCER,” L. Avvento, MD, S. Gordon, MD, J. M. Silberberg, MD, M. H. Zarrabi, MD, FACP, S. Zucker, MD, FACP, Am. J. Hematol., 1988:Mar;27 (3):221-3.

• “AN UNUSUAL CASE OF CHRONIC LYMPHOCYTIC LEUKEMIA,” S. L. Hollander, J. of Med. Vol. 22 Nos. 4&5, P.289-297, 1991.

• “REVIEW OF PLATINUM ANTICANCER COMPOUNDS,” M. Gordon and S. L. Hollander, J. of Med.: Vol.24, Nos. 4&5, P.209-265, 1993.

• “THE ROLE OF PRIMARY CARE IN CANCER SCREENING AND PREVENTION,” Findings, Vol.2 No.1 P. 18-19, 1993, S. L. Hollander.

• “RETROSPECTIVE ANALYSIS OF FIVE YEAR EXPERIENCE WITH CARCINOMA OF THE ESOPHAGUS,” Middleman, E. L., Hollander, S. L., Meltzer, J. I., Nazha, N. T. and Cassir, J. F. (Abstract)

• “RECOMBINANT ERYTHROPOIETIN IN -THALASSEMIA INTERMEDIA: A CASE STUDY”, Findings, Vol.9, p.76-78, 2000, S. L. Hollander.

• “HODGKIN’S DISEASE OF THE NASOPHARYNX,” S. L. Hollander, JCO, Vol. 22, No. 1, Jan. 1, 2004, p. 195 – 196.

• “THE PLATEAU IN CYTOTOXIC CANCER DRUG DISCOVERY – AN UPDATE SIXTEEN YEARS LATER, INCLUDING EMERGENT TARGETING OF CANCER DRUGS,” Sandra Hollander, MD, FACP and Maxwell Gordon, PhD, J. of Med. Vol. 36 (1-6), p. 147-167.

Dr. Sandra Hollander, M.D., F.A.C.P. is triple board certified in Internal Medicine, Hematology and Oncology.  She earned her Master’s Degree in Experimental Pathology and was motivated into the field of Oncology by her father, Dr. Maxwell Gordon who was the developer of one of the breakthrough cancer drugs, cis – Platinum.

Dr Sandra Hollander has an extensive background having practiced as an Assistant Professor of Hematology and Oncology at the University of Medicine and Dentistry of New Jersey and Atlantic Hematology Oncology Group, a community based practice in Galloway, NJ for over 20 years.   She served as Director of the Division of Hematology and Oncology at AtlantiCare Regional Medical Center.